Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication

Abstract Liver stiffness measurement (LSM) is a useful tool for assessing advanced liver fibrosis, an important risk factor for hepatocellular carcinoma (HCC) following hepatitis C (HCV) eradication. This study aimed to clarify the non-invasive factors associated with HCC following sustained virolog...

Full description

Bibliographic Details
Main Authors: Masato Nakai, Yoshiya Yamamoto, Masaru Baba, Goki Suda, Akinori Kubo, Yoshimasa Tokuchi, Takashi Kitagataya, Ren Yamada, Taku Shigesawa, Kazuharu Suzuki, Akihisa Nakamura, Takuya Sho, Kenichi Morikawa, Koji Ogawa, Ken Furuya, Naoya Sakamoto
Format: Article
Language:English
Published: Nature Portfolio 2022-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-05492-5
_version_ 1818333150456053760
author Masato Nakai
Yoshiya Yamamoto
Masaru Baba
Goki Suda
Akinori Kubo
Yoshimasa Tokuchi
Takashi Kitagataya
Ren Yamada
Taku Shigesawa
Kazuharu Suzuki
Akihisa Nakamura
Takuya Sho
Kenichi Morikawa
Koji Ogawa
Ken Furuya
Naoya Sakamoto
author_facet Masato Nakai
Yoshiya Yamamoto
Masaru Baba
Goki Suda
Akinori Kubo
Yoshimasa Tokuchi
Takashi Kitagataya
Ren Yamada
Taku Shigesawa
Kazuharu Suzuki
Akihisa Nakamura
Takuya Sho
Kenichi Morikawa
Koji Ogawa
Ken Furuya
Naoya Sakamoto
author_sort Masato Nakai
collection DOAJ
description Abstract Liver stiffness measurement (LSM) is a useful tool for assessing advanced liver fibrosis, an important risk factor for hepatocellular carcinoma (HCC) following hepatitis C (HCV) eradication. This study aimed to clarify the non-invasive factors associated with HCC following sustained virological response (SVR) and to identify the low-risk group. 567 patients without history of HCC who achieved SVR at 24 weeks (SVR24) after IFN-free treatment were retrospectively analyzed. The cumulative incidence of HCC and the risk factors were examined using pre-treatment and SVR24 data. The median observation period was 50.2 months. Thirty cases of HCC were observed, and the 4-year cumulative incidence of HCC was 5.9%. In multivariate analysis, significant pre-treatment factors were age ≥ 71 years (hazard ratio [HR]: 3.402) and LSM ≥ 9.2 kPa (HR: 6.328); SVR24 factors were age ≥ 71 years (HR: 2.689) and LSM ≥ 8.4 kPa (HR: 6.642). In cases with age < 71 years and LSM < 8.4 kPa at the time of SVR24, the 4-year cumulative incidence of HCC was as low as 1.1%. Both pre-treatment LSM (≥ 9.2 kPa) and SVR24 LSM (≥ 8.4 kPa) and age (≥ 71 years) are useful in predicting the risk of HCC after SVR with IFN-free treatment. Identification of low-risk individuals may improve the efficiency of follow-up.
first_indexed 2024-12-13T13:47:04Z
format Article
id doaj.art-7d4cef0345414ea29ae87e92e6a05592
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-13T13:47:04Z
publishDate 2022-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-7d4cef0345414ea29ae87e92e6a055922022-12-21T23:43:22ZengNature PortfolioScientific Reports2045-23222022-01-0112111010.1038/s41598-022-05492-5Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradicationMasato Nakai0Yoshiya Yamamoto1Masaru Baba2Goki Suda3Akinori Kubo4Yoshimasa Tokuchi5Takashi Kitagataya6Ren Yamada7Taku Shigesawa8Kazuharu Suzuki9Akihisa Nakamura10Takuya Sho11Kenichi Morikawa12Koji Ogawa13Ken Furuya14Naoya Sakamoto15Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido UniversityDepartment of Gastroenterology, Hakodate Municipal HospitalDepartment of Gastroenterology, JCHO Hokkaido HospitalDepartment of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido UniversityDepartment of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido UniversityDepartment of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido UniversityDepartment of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido UniversityDepartment of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido UniversityDepartment of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido UniversityDepartment of Gastroenterology, Hakodate Municipal HospitalDepartment of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido UniversityDepartment of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido UniversityDepartment of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido UniversityDepartment of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido UniversityDepartment of Gastroenterology, JCHO Hokkaido HospitalDepartment of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido UniversityAbstract Liver stiffness measurement (LSM) is a useful tool for assessing advanced liver fibrosis, an important risk factor for hepatocellular carcinoma (HCC) following hepatitis C (HCV) eradication. This study aimed to clarify the non-invasive factors associated with HCC following sustained virological response (SVR) and to identify the low-risk group. 567 patients without history of HCC who achieved SVR at 24 weeks (SVR24) after IFN-free treatment were retrospectively analyzed. The cumulative incidence of HCC and the risk factors were examined using pre-treatment and SVR24 data. The median observation period was 50.2 months. Thirty cases of HCC were observed, and the 4-year cumulative incidence of HCC was 5.9%. In multivariate analysis, significant pre-treatment factors were age ≥ 71 years (hazard ratio [HR]: 3.402) and LSM ≥ 9.2 kPa (HR: 6.328); SVR24 factors were age ≥ 71 years (HR: 2.689) and LSM ≥ 8.4 kPa (HR: 6.642). In cases with age < 71 years and LSM < 8.4 kPa at the time of SVR24, the 4-year cumulative incidence of HCC was as low as 1.1%. Both pre-treatment LSM (≥ 9.2 kPa) and SVR24 LSM (≥ 8.4 kPa) and age (≥ 71 years) are useful in predicting the risk of HCC after SVR with IFN-free treatment. Identification of low-risk individuals may improve the efficiency of follow-up.https://doi.org/10.1038/s41598-022-05492-5
spellingShingle Masato Nakai
Yoshiya Yamamoto
Masaru Baba
Goki Suda
Akinori Kubo
Yoshimasa Tokuchi
Takashi Kitagataya
Ren Yamada
Taku Shigesawa
Kazuharu Suzuki
Akihisa Nakamura
Takuya Sho
Kenichi Morikawa
Koji Ogawa
Ken Furuya
Naoya Sakamoto
Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication
Scientific Reports
title Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication
title_full Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication
title_fullStr Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication
title_full_unstemmed Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication
title_short Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication
title_sort prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis c virus eradication
url https://doi.org/10.1038/s41598-022-05492-5
work_keys_str_mv AT masatonakai predictionofhepatocellularcarcinomausingageandliverstiffnessontransientelastographyafterhepatitiscviruseradication
AT yoshiyayamamoto predictionofhepatocellularcarcinomausingageandliverstiffnessontransientelastographyafterhepatitiscviruseradication
AT masarubaba predictionofhepatocellularcarcinomausingageandliverstiffnessontransientelastographyafterhepatitiscviruseradication
AT gokisuda predictionofhepatocellularcarcinomausingageandliverstiffnessontransientelastographyafterhepatitiscviruseradication
AT akinorikubo predictionofhepatocellularcarcinomausingageandliverstiffnessontransientelastographyafterhepatitiscviruseradication
AT yoshimasatokuchi predictionofhepatocellularcarcinomausingageandliverstiffnessontransientelastographyafterhepatitiscviruseradication
AT takashikitagataya predictionofhepatocellularcarcinomausingageandliverstiffnessontransientelastographyafterhepatitiscviruseradication
AT renyamada predictionofhepatocellularcarcinomausingageandliverstiffnessontransientelastographyafterhepatitiscviruseradication
AT takushigesawa predictionofhepatocellularcarcinomausingageandliverstiffnessontransientelastographyafterhepatitiscviruseradication
AT kazuharusuzuki predictionofhepatocellularcarcinomausingageandliverstiffnessontransientelastographyafterhepatitiscviruseradication
AT akihisanakamura predictionofhepatocellularcarcinomausingageandliverstiffnessontransientelastographyafterhepatitiscviruseradication
AT takuyasho predictionofhepatocellularcarcinomausingageandliverstiffnessontransientelastographyafterhepatitiscviruseradication
AT kenichimorikawa predictionofhepatocellularcarcinomausingageandliverstiffnessontransientelastographyafterhepatitiscviruseradication
AT kojiogawa predictionofhepatocellularcarcinomausingageandliverstiffnessontransientelastographyafterhepatitiscviruseradication
AT kenfuruya predictionofhepatocellularcarcinomausingageandliverstiffnessontransientelastographyafterhepatitiscviruseradication
AT naoyasakamoto predictionofhepatocellularcarcinomausingageandliverstiffnessontransientelastographyafterhepatitiscviruseradication